These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17287747)

  • 21. Snakebite in the tropics: experience in Makurdi, Nigeria.
    Idoko A; Ikwueke K
    Trop Geogr Med; 1984 Jun; 36(2):175-80. PubMed ID: 6332397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of Snakebites in Sub-Saharan Africa].
    Chippaux JP
    Med Sante Trop; 2015; 25(3):245-8. PubMed ID: 26039508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How health systems in sub-Saharan Africa can benefit from tuberculosis and other infectious disease programmes.
    Harries AD; Jensen PM; Zachariah R; Rusen ID; Enarson DA
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1194-9. PubMed ID: 19793422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa.
    Hamza M; Idris MA; Maiyaki MB; Lamorde M; Chippaux JP; Warrell DA; Kuznik A; Habib AG
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004568. PubMed ID: 27027633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anti snake venom crisis in Africa: a suggested manufacturers product guide.
    Simpson ID; Blaylock RS
    Wilderness Environ Med; 2009; 20(3):275-82. PubMed ID: 19737031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The public health workforce in sub-Saharan Africa: challenges and opportunities.
    Beaglehole R; Sanders D; Dal Poz M
    Ethn Dis; 2003; 13(2 Suppl 2):S24-30. PubMed ID: 13677409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A survey on the venomous snakes of the vicinity of Kindia (Guinea) and considerations on the treatment of snakebite].
    Baldé MC; Mané Y; Trape JF
    Med Trop (Mars); 2009 Feb; 69(1):37-40. PubMed ID: 19499730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of snakebite and systemic envenomation in rural Ecuador using the 20-minute whole blood clotting test.
    Gaus DP; Herrera DF; Troya CJ; Guevara AH
    Wilderness Environ Med; 2013 Dec; 24(4):345-50. PubMed ID: 24119570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Snake venoms and antivenoms: critical supply issues.
    Bawaskar HS
    J Assoc Physicians India; 2004 Jan; 52():11-3. PubMed ID: 15633710
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of snake bite cases at Liaquat University Hospital Hyderabad/Jamshoro.
    Hayat AS; Khan AH; Shaikh TZ; Ghouri RA; Shaikh N
    J Ayub Med Coll Abbottabad; 2008; 20(3):125-7. PubMed ID: 19610536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.
    Currie BJ
    Toxicon; 2006 Dec; 48(7):941-56. PubMed ID: 16930660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and prospects of snake antivenom supply in sub-Saharan Africa.
    Habib AG; Musa BM; Iliyasu G; Hamza M; Kuznik A; Chippaux JP
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008374. PubMed ID: 32817674
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of snakebite in Zimbabwe.
    Blaylock RS
    Cent Afr J Med; 1982 Oct; 28(10):237-46. PubMed ID: 6762927
    [No Abstract]   [Full Text] [Related]  

  • 34. Snakebite burden in Sub-Saharan Africa: estimates from 41 countries.
    Halilu S; Iliyasu G; Hamza M; Chippaux JP; Kuznik A; Habib AG
    Toxicon; 2019 Mar; 159():1-4. PubMed ID: 30594637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development and use of immunotherapy in Africa.
    Chippaux JP
    Toxicon; 1998 Nov; 36(11):1503-6. PubMed ID: 9792164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.
    Potet J; Smith J; McIver L
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007551. PubMed ID: 31233536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Validity of a test for diagnosis and monitoring of hemorrhagic syndrome after viper envenomation in sub-saharan Africa].
    Chippaux JP; Amadi-Eddine S; Fagot P
    Med Trop (Mars); 1998; 58(4):369-71. PubMed ID: 10399695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A locally developed snakebite management protocol significantly reduces overall anti snake venom utilization in West Bengal, India.
    Ghosh S; Maisnam I; Murmu BK; Mitra PK; Roy A; Simpson ID
    Wilderness Environ Med; 2008; 19(4):267-74. PubMed ID: 19099337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context.
    Brown NI
    PLoS Negl Trop Dis; 2012; 6(6):e1670. PubMed ID: 22679521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in sub-Saharan Africa: what physicians can do!
    Alderman MH
    Am J Hypertens; 2009 Jun; 22(6):581-2. PubMed ID: 19455187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.